Hepatitis C: A challenge for the generalist

Hospital Practice

Volumn 35, Issue 1, 2000, Pages 97-118

  Catalina, Gabriel ^a   Navarro, Victor ^b,c  

^a Connecticut Emerging Infections P ^*  (United States)

^b Liver Study Unit   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA2A INTERFERON; ALPHA2B INTERFERON; BILIRUBIN; PROTHROMBIN; RIBAVIRIN; VIRUS RNA;

ANEMIA; BLOOD TRANSFUSION; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEVER; FLU LIKE SYNDROME; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALAISE; MYALGIA; NAUSEA; PERINATAL INFECTION; REVIEW; RISK FACTOR; SEXUAL TRANSMISSION; TATTOOING; UNITED STATES; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0034650746     PISSN: 87502836     EISSN: None     Source Type: Journal    
DOI: 10.3810/hp.2000.01.180     Document Type: Review

References (14)

1. Adams PC. Iron overload in viral and alcoholic liver disease. J Hepatol 28(Suppl 1):19, 1998
2. Alter MJ. Epidemiology of hepatitis C. Hepatology 26(Suppl 1):62S, 1997
3. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 15:5, 1995
4. Alter MJ et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 264:2231, 1990
5. Boker KH et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 25:203, 1997
6. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV- related chronic disease. MMWR 47(RR-19):1, 1998
7. Davis GL et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 339:1493, 1998
8. Hoofnagle JH, Hepatitis C. The clinical spectrum of disease. Hepatology 26(Suppl 1):15S, 1997
9. Fattovich G et al. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients. Gastroenterology 112:463, 1997
10. McHutchison JG et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339:1485, 1998
11. National Institutes of Health Consensus Conference Panel. Management of hepatitis C. Hepatology 26(Suppl 1):IS, 1997
12. Pugh RNH et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646, 1973
13. Schreiber GB et al. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 334:1685, 1996
14. Wiley TE et al. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 28:805, 1998